J. Daniel O'Connor's most recent trade in Seelos Therapeutics Inc was a trade of 1,666 Stock Option (right to buy) done . Disclosure was reported to the exchange on Jan. 4, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Seelos Therapeutics Inc | J. Daniel O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Jan 2024 | 1,666 | 1,666 | - | - | Stock Option (right to buy) | |
| Seelos Therapeutics Inc | Daniel J. O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2023 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Seelos Therapeutics Inc | Daniel J. O'Connor | Director | Purchase of securities on an exchange or from another person at price $ 0.61 per share. | 01 Jun 2022 | 16,000 | 16,000 (0%) | 0% | 0.6 | 9,789 | Common Stock |
| Seelos Therapeutics Inc | Daniel J. O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2022 | 35,000 | 35,000 | - | - | Stock Option (right to buy) | |
| Seelos Therapeutics Inc | Daniel J. O'Connor | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jan 2021 | 16,000 | 16,000 | - | - | Stock Option (right to buy) |